StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
111
This month
6
This week
1
This year
47
Yesterday
1
Publishing Date
2024 - 03 - 22
2
2024 - 03 - 11
2
2024 - 03 - 08
2
2024 - 02 - 29
2
2024 - 02 - 23
2
2024 - 02 - 15
2
2024 - 02 - 12
2
2024 - 02 - 02
2
2024 - 01 - 25
2
2024 - 01 - 17
2
2024 - 01 - 15
2
2024 - 01 - 03
2
2023 - 12 - 22
2
2023 - 11 - 21
1
2023 - 11 - 17
1
2023 - 11 - 10
1
2023 - 11 - 02
1
2023 - 10 - 30
1
2023 - 10 - 27
1
2023 - 10 - 23
2
2023 - 10 - 20
1
2023 - 10 - 17
1
2023 - 10 - 13
2
2023 - 10 - 10
2
2023 - 10 - 06
2
2023 - 10 - 05
2
2023 - 10 - 02
2
2023 - 09 - 29
1
2023 - 09 - 26
1
2023 - 09 - 22
1
2023 - 09 - 20
1
2023 - 09 - 15
1
2023 - 09 - 14
1
2023 - 09 - 11
1
2023 - 09 - 08
1
2023 - 09 - 07
1
2023 - 08 - 30
1
2023 - 08 - 25
1
2023 - 08 - 23
1
2023 - 08 - 18
1
2023 - 08 - 15
1
2023 - 08 - 11
2
2023 - 08 - 04
1
2023 - 08 - 01
1
2023 - 07 - 28
2
2023 - 07 - 24
1
2023 - 07 - 21
3
2023 - 07 - 20
1
2023 - 04 - 27
1
2023 - 03 - 27
1
2023 - 03 - 06
1
2022 - 12 - 07
1
2021 - 09 - 21
1
2021 - 09 - 08
1
2021 - 07 - 19
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 07 - 01
1
2021 - 06 - 04
1
2021 - 03 - 17
1
Sector
Consumer non-durables
4
Health technology
111
Manufacturing
3
N/a
2
Process industries
3
Tags
Acquisition
3
Acquisitions
1
Actemra
1
Advanced
1
Anemia
1
Animal
1
Animals
1
Approval
14
Approved
7
Astrazeneca
4
Biosimilar
2
Biotechnology
14
Bladder
1
Blood
1
Breast
1
Breyanzi
1
Brukinsa
1
Cancer
6
Cell
1
Cosentyx
2
Covid-19
3
Diagnostics
1
Disease
3
Distribution
1
Dmd
1
Drug
12
Dupixent
4
Ev
1
Expansion
1
Fda
81
Fda-approvals
28
First
6
For
4
Global
6
Growing
2
Growth
2
Hypertension
3
Immunotherapy
2
Keytruda
4
Kids
2
Market
8
Merck
2
N/a
17
News
14
Novartis
2
Nutrition
2
Pancreatic
2
Pharmaceutical
13
Psoriasis
2
Rare
4
Regulatory
25
Report
4
Research
2
Sanofi
3
Schizophrenia
3
Therapeutics
3
Therapy
5
Treatment
13
Week
2
Wegovy
2
Entities
Abbott laboratories
251
Abbvie inc.
211
Alnylam pharmaceuticals, inc.
78
Alphabet inc.
32
Amarin corporation plc
31
Amgen inc.
170
Astellas pharma inc
70
Astrazeneca plc
213
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
30
Baxter international inc.
45
Becton, dickinson and company
34
Biogen inc.
53
Biomarin pharmaceutical inc.
29
Biontech se
167
Blueprint medicines corporation
20
Boston scientific corporation
25
Bristol-myers squibb company
119
Byline bancorp, inc.
26
Clovis oncology, inc.
20
Csl ltd
22
Denali therapeutics inc.
22
Eli lilly and company
335
Endo international plc
20
Galapagos nv
36
Gilead sciences, inc.
64
Glaxosmithkline plc
334
Igm biosciences, inc.
37
Incyte corporation
121
Innate pharma s.a.
109
Innate pharma sa
81
Johnson & johnson
571
Karyopharm therapeutics inc.
25
Kymera therapeutics, inc.
29
Ligand pharmaceuticals incorporated
20
Medtronic plc
45
Mobiv acquisition corp
65
Moderna, inc.
34
Morphosys ag
36
Nektar therapeutics
43
Novartis ag
329
Novo nordisk a/s
139
Oncocyte corporation
32
Orange
49
Perrigo company
111
Pfizer, inc.
153
Provention bio, inc.
283
Ptc therapeutics, inc.
32
Rallybio corp
31
Rcf acquisition corp.
83
Regeneron pharmaceuticals, inc.
254
Sanofi
4539
Takeda pharmaceutical company limited
60
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
31
Thermo fisher scientific inc
43
Translate bio, inc.
21
Vaxart, inc.
33
Viatris inc.
87
Vir biotechnology, inc.
22
Symbols
ABBV
2
ABT
68
ADMP
1
ALB
1
ALKS
2
ALLO
1
ARDX
1
ARMV
1
ARRY
1
ARVL
1
ATNX
1
AZN
4
AZNCF
4
BAX
2
BFAGY
1
BFFTF
1
BHC
6
BIIB
1
BMAQ
1
BMY
2
BRBR
2
BRO
1
CAPR
1
CENT
2
CENTA
2
CL
3
CMXHF
1
CPB
1
CSLLY
1
CTLT
1
DRI
1
ELAN
3
ENDP
3
ENDPQ
1
ERIC
1
FNCTF
2
GLAXF
11
GSK
15
JNJ
99
KHC
3
LLY
9
MDT
2
MEDE
2
NVS
8
NVSEF
7
PBH
2
PFE
2
PMD
2
PRGO
222
RBGLY
6
RBGPF
6
SLGL
3
SNOA
2
SNY
111
SNYNF
103
TARO
3
TEVA
2
TEVJF
6
VTRS
3
ZTS
5
Exchanges
Nasdaq
111
Nyse
111
Crawled Date
2024 - 03 - 22
2
2024 - 03 - 11
2
2024 - 03 - 08
2
2024 - 02 - 29
2
2024 - 02 - 23
2
2024 - 02 - 15
2
2024 - 02 - 12
2
2024 - 02 - 02
2
2024 - 01 - 25
2
2024 - 01 - 17
2
2024 - 01 - 15
2
2024 - 01 - 03
2
2023 - 12 - 22
2
2023 - 11 - 21
1
2023 - 11 - 17
1
2023 - 11 - 10
1
2023 - 11 - 02
1
2023 - 10 - 30
1
2023 - 10 - 27
1
2023 - 10 - 23
2
2023 - 10 - 20
1
2023 - 10 - 17
1
2023 - 10 - 13
2
2023 - 10 - 10
2
2023 - 10 - 06
2
2023 - 10 - 05
2
2023 - 10 - 02
2
2023 - 09 - 29
1
2023 - 09 - 26
1
2023 - 09 - 22
1
2023 - 09 - 20
1
2023 - 09 - 15
1
2023 - 09 - 14
1
2023 - 09 - 11
1
2023 - 09 - 08
1
2023 - 09 - 07
1
2023 - 08 - 30
1
2023 - 08 - 25
1
2023 - 08 - 23
1
2023 - 08 - 18
1
2023 - 08 - 15
1
2023 - 08 - 11
2
2023 - 08 - 04
1
2023 - 08 - 01
1
2023 - 07 - 28
2
2023 - 07 - 24
1
2023 - 07 - 21
3
2023 - 07 - 20
1
2023 - 04 - 28
1
2023 - 03 - 27
1
2023 - 03 - 06
1
2022 - 12 - 07
1
2021 - 09 - 21
1
2021 - 09 - 08
1
2021 - 07 - 19
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 07 - 01
1
2021 - 06 - 04
1
2021 - 03 - 17
1
Crawled Time
00:00
1
02:00
1
04:00
1
08:00
1
11:00
1
12:30
1
13:00
3
13:20
2
13:30
7
14:00
8
14:15
1
14:20
1
14:30
14
15:00
18
15:20
1
15:30
10
16:00
9
17:00
15
17:02
1
18:00
2
19:00
2
20:00
1
21:00
3
22:00
2
23:00
5
Source
www.biospace.com
94
www.fda.gov
1
www.prnewswire.com
16
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Perrigo company
symbols :
SNY
save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published:
2024-04-19
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
2.53%
|
O:
-0.4%
H:
3.01%
C:
2.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
2.04%
|
O:
0.83%
H:
1.35%
C:
1.2%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
0.83%
|
O:
-0.39%
H:
1.69%
C:
1.23%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.74%
|
O:
0.83%
H:
1.83%
C:
0.89%
first
treatment
for
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published:
2024-04-12
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.53%
|
O:
-0.13%
H:
0.0%
C:
-2.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-1.85%
|
O:
-1.65%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.74%
|
O:
-1.06%
H:
0.21%
C:
-1.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.33%
|
O:
-3.02%
H:
0.0%
C:
0.0%
drug
label
astrazeneca
expansion
for
kids
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published:
2024-04-08
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.91%
|
O:
0.96%
H:
1.17%
C:
0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.03%
|
O:
-0.48%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.53%
|
O:
0.09%
H:
0.16%
C:
-0.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.33%
|
O:
0.84%
H:
0.0%
C:
0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published:
2024-04-05
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.07%
|
O:
-0.22%
H:
0.8%
C:
0.06%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.81%
|
O:
-1.84%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.57%
|
O:
-0.37%
H:
1.42%
C:
1.37%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.72%
|
O:
-3.44%
H:
0.0%
C:
0.0%
fda
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published:
2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.66%
|
O:
-0.29%
H:
1.34%
C:
-0.64%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.23%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.23%
|
O:
0.11%
H:
0.37%
C:
-0.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.94%
|
O:
0.69%
H:
0.0%
C:
0.0%
fda
drug
schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published:
2024-04-02
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.08%
|
O:
-1.09%
H:
0.13%
C:
-1.39%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.26%
|
O:
-0.77%
H:
0.8%
C:
0.74%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.29%
|
O:
-0.18%
H:
0.47%
C:
0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.05%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
approval
astrazeneca
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published:
2024-03-29
(Crawled : 19:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
fda
hepatitis
kidney
anemia
FDA Approves New Treatments for Two Rare Diseases
Published:
2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
0.0%
|
O:
0.84%
H:
1.48%
C:
1.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.96%
|
O:
0.3%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.86%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.89%
|
O:
1.06%
H:
0.0%
C:
0.0%
fda
rare
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published:
2024-03-25
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.09%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.66%
|
O:
0.35%
H:
0.35%
C:
-1.34%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.92%
|
O:
0.04%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.98%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.68%
|
O:
0.42%
H:
0.0%
C:
0.0%
approved
treatment
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published:
2024-03-22
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.47%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.21%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.44%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published:
2024-03-22
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.47%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.21%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.44%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published:
2024-03-21
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.6%
|
O:
0.0%
H:
1.6%
C:
0.89%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.93%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.75%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.16%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
drug
iclusig
hypertension
FDA Approves First Gene Therapy for Rare Pediatric Disease
Published:
2024-03-18
(Crawled : 23:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.42%
|
O:
0.33%
H:
0.13%
C:
-1.51%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.53%
|
O:
0.2%
H:
0.08%
C:
-1.14%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.41%
|
O:
1.71%
H:
0.36%
C:
-2.52%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.38%
|
O:
-0.81%
H:
0.0%
C:
0.0%
fda
rare
first
disease
therapy
Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published:
2024-03-15
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-0.23%
|
O:
-0.62%
H:
0.59%
C:
-1.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.64%
|
O:
-5.53%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
fda
breyanzi
week
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.82%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.94%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.18%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.66%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published:
2024-03-11
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.82%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.94%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.18%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.66%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published:
2024-03-08
(Crawled : 18:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
3.74%
|
O:
0.98%
H:
3.17%
C:
0.9%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.57%
|
O:
-0.68%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.67%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.74%
|
O:
-0.08%
H:
0.0%
C:
0.0%
fda
brukinsa
approval
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa; Opdivo Approved for B...
Published:
2024-03-08
(Crawled : 17:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
3.74%
|
O:
0.98%
H:
3.17%
C:
0.9%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.57%
|
O:
-0.68%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.67%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.74%
|
O:
-0.08%
H:
0.0%
C:
0.0%
fda
opdivo
approved
approval
Decision Tracker: FDA Decisions: Amgen’s Bone-Preserving Blockbuster Picks Up Two New Challengers
Published:
2024-03-06
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
12.99%
|
O:
-0.15%
H:
3.43%
C:
3.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.93%
|
O:
-0.67%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.9%
|
O:
-1.65%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.63%
|
O:
-0.45%
H:
0.0%
C:
0.0%
fda
Global Synthetic Hormones Market Analysis and Forecast 2023-2033: Hospital Pharmacies to Continue its Dominance in the Global Synthetic Hormones Market by End User
Published:
2024-03-05
(Crawled : 04:00)
- prnewswire.com
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
17.42%
|
O:
1.03%
H:
2.96%
C:
2.87%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
1.17%
H:
0.0%
C:
0.0%
hospital
global
market
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.